New study tracks Long-Term safety of leading CF drug in young children
NCT ID NCT06460506
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 25 times
Summary
This study looks at the long-term safety and how well the body handles a drug combination (elexacaftor/tezacaftor/ivacaftor, also known as Trikafta) in people with cystic fibrosis who are 12 months old or older. About 50 participants who completed a previous study will continue taking the medication. Researchers will monitor side effects and measure sweat chloride levels to see how well the treatment is working.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alder Hey Children's NHS Foundation Trust
Liverpool, United Kingdom
-
British Columbia Children's Hospital
Vancouver, Canada
-
Charité Universitätsmedizin BerlinX
Berlin, Germany
-
Children and Young Adults Research Unit
Cardiff, United Kingdom
-
Erasmus Medical Center
Rotterdam, Netherlands
-
Great Ormond Street Hospital for Children
London, United Kingdom
-
Inselspital - Universitaetsspital Bern
Bern, Switzerland
-
Juliane Marie Center, Rigshospitalet
Copenhagen, Denmark
-
Kinderklinik III, Abt. fur Pneumologie
Essen, Germany
-
Kinderspital Zurich
Zurich, Switzerland
-
Leeds General Infirmary
Leeds, United Kingdom
-
Medizinische Hochschule Hannover
Hanover, Germany
-
Queensland Children's Hospital
South Brisbane, Australia
-
Royal Brompton Hospital
London, United Kingdom
-
Southampton General Hospital
Southampton, United Kingdom
-
The Hospital for Sick Children
Toronto, Canada
-
The Kids Research Institute Australia
Nedlands, Australia
-
The Royal Children's Hospital
Parkville, Australia
Conditions
Explore the condition pages connected to this study.